• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Fulminant reversible cerebral vasoconstriction syndrome in breakthrough COVID 19 infection
We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay.
Source: Journal of Stroke and Cerebrovascular Diseases - November 25, 2021 Category: Neurology Authors: Somdattaa Ray, Vikram V Kamath, Arjun Raju P, Rajesh K.N, Shalini N Source Type: research

PRES and RCVS: Two Distinct Entities or a Spectrum of the Same Disease?
Posterior reversible encephalopathy syndrome (PRES) is a disorder characterized by vasogenic edema predominantly in the parieto-occipital regions associated with acute onset of neurological symptoms including encephalopathy, seizures, headache, and visual disturbances. It has been classically associated with uncontrolled hypertension, renal failure, exposure to cytotoxic agents, or pre-eclampsia.1,2 Despite its name, PRES it is not universally posterior nor fully reversible. Up to 10-20% of patients can have persistent neurological sequelae,1 therefore prompt recognition and elimination of triggering factors is of paramount importance.
Source: Journal of Stroke and Cerebrovascular Diseases - April 5, 2022 Category: Neurology Authors: Valerie Jeanneret, Dinesh V. Jillella, Srikant Rangaraju, Olivia Groover, Ryan Peterson, Sitara Koneru, Fadi Nahab, Carlos S. Kase Tags: Short Communication Source Type: research

R558C NOTCH3 Mutation in a CADASIL Patient with Intracerebral Hemorrhage: A Case Report with Literature Review
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic cerebral small-vessel disease, which is characterized by migraine, recurrent ischemic strokes, psychiatric disorder, progressive cognitive decline, and occasionally intracerebral hemorrhage (ICH). ICH events have been reported in a high proportion of East Asian CADASIL patients with R544C mutation in exon 11 of NOTCH3; however, whether any other specific NOTCH3 mutation determines the ICH phenotype has yet to be explored.
Source: Journal of Stroke and Cerebrovascular Diseases - May 3, 2022 Category: Neurology Authors: Liuting Hu, Gang Liu, Yuhua Fan Tags: Case Report Source Type: research

Infratentorial developmental venous anomaly concurrent with a cavernoma and dural arteriovenous fistula
A 32-year-old woman underwent a head computed tomography scan after a traffic accident. A calcification in the left cerebellar hemisphere was disclosed. She did not complain of any symptoms, but neurological examination revealed cerebellar ataxia. She did not have any preceding episodes since birth, such as acute-onset headache. Magnetic resonance imaging showed past hemorrhage of the calcification lesion suggestive of a cerebellar cavernoma. A dilated vascular structure was also observed (Fig.  1A, B).
Source: Journal of Stroke and Cerebrovascular Diseases - July 14, 2022 Category: Neurology Authors: Hirokuni Hashikata, Yoshinori Maki, Ryota Ishibashi, Masanori Goto, Hiroki Toda Tags: Case Report Source Type: research

Diagnostic accuracy of MR vessel wall imaging at 2 weeks to predict morphological healing of vertebral artery dissection
Patients with non-hemorrhagic intracranial vertebral artery dissection (VAD) exhibit various symptoms including severe occipital headache alone or focal neurological deficits caused by vertebrobasilar artery ischemia.1 The majority of non-hemorrhagic VAD have a benign clinical course and spontaneously resolve.2, 3 The time course of changes in the imaging characteristics of VAD remains unclear and a follow-up management strategy has not yet been established.4 Since cerebrovascular dissections occur within the cerebrovascular wall, it is important to evaluate the vascular wall to determine whether the dissection has healed spontaneously.
Source: Journal of Stroke and Cerebrovascular Diseases - August 26, 2022 Category: Neurology Authors: Yukishige Hashimoto, Toshinori Matsushige, Reo Kawano, Michitsura Yoshiyama, Takeshi Hara, Shohei Kobayashi, Chiaki Ono, Shigeyuki, Sakamoto, Nobutaka Horie Source Type: research

Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
Fatal complications have occurred after vaccination with ChAdOx1 nCoV-19, a vaccine against Covid-19. Vaccine-induced immune thrombotic thrombocytopenia (VITT) with severe outcome is characterized by venous thrombosis, predominantly in cerebral veins, thrombocytopenia and anti-PF4/polyanion antibodies. Prolonged headaches and cutaneous hemorrhages, frequently observed after the ChAdOx1 nCoV-19 vaccine, have therefore caused anxiety among vaccinees. We investigated whether these symptoms represent a mild form of VITT, with a potential for aggravation, e.g.
Source: Journal of Stroke and Cerebrovascular Diseases - November 17, 2022 Category: Neurology Authors: Nina Haagenrud Schultz, Arne Vasli Lund S øraas, Ingvild Hausberg Sørvoll, Çigdem Akalin Akkök, Annette Vetlesen, Jagjit Singh Bhamra, Maria Therese Ahlen, Pål Andre Holme, Anne-Hege Aamodt, Karolina Skagen, Thor Håkon Skattør, Mona Skjelland, Mark Source Type: research

Comment on vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine
Dear Editor, we would like to share ideas on the publication “Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study1.” If these symptoms are a minor form of VITT, with a possibility for worsening, such as in the case of a second vaccination dose, or a new entity of vaccine consequences, Schultz et al. ex plored this1. The combination of headaches and subcutaneous hemorrhage, according to Schultz et al., did not indicate VITT, and no other distinct coagulation problem or cerebral pathology was discovered.
Source: Journal of Stroke and Cerebrovascular Diseases - January 23, 2023 Category: Neurology Authors: Rujittika Mungmunpuntipantip, Viroj Wiwanitkit Tags: Letter to the Editor Source Type: research

Pages: 1  2  3  4  5  6  7  8